Research Finds Risk of Heart Attack Higher in Pradaxa Users

Posted by Firm Staff on May 16, 2017 1:27:17 PM
Find me on:

Pradaxa-0517-FandHLaw.jpegA study published by CBS News finds Pradaxa users at a 33% higher risk of developing heart disease or heart attack when compared to warfarin users. An editorial accompanying this study notes this isn’t the first safety warning issued for the anti-clotting drug Pradaxa.

According to the article, the FDA is investigating an abnormally large number of reports of serious bleeding associated with Pradaxa. This is in addition to research finding patients taking the blood-thinning medication at a 33% higher risk of developing adverse coronary effects.

 

"The risk of acute coronary syndrome is increased with [Pradaxa] compared with various control treatments, which include adjusted-dose warfarin," claims Cleveland Clinic researcher Ken Uchino, MD.

 

Pradaxa-1-FANDHLAW.jpgIf you or a loved one has taken Pradaxa, it’s important to be aware of the potential effects and your rights. If you have any immediate questions regarding your health or medical prescriptions, please consult your primary physician.

 

To help you stay informed, The Law Offices of Foster & Houston will continue to share important news involving Pradaxa. If you’ve taken Pradaxa and have suffered excessive or uncontrollable bleeding, you may be able to obtain compensation for your injury. You can learn more about seeking justice and Pradaxa by visiting our website or calling (800) 336-6230.

 

Sources: CBS News


 

 
Additional Pradaxa Resources:

Topics: Health News, Health, Health Study, Health Research, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Pradaxa, Pradaxa Lawsuit, Pradaxa Law, Pradaxa Lawyer, Pradaxa Attorney, Stroke

Contact Foster & Houston

More to Read